5 Points to Consider when Evaluating your CMO’s Analytical Capabilities

Posted: March 23, 2018

Author:
Tags: Analytical Methods | Video | Video Series - How to Select a CMO
API Manufacturing and Pharmaceutical Manufacturing




Part 3 of our “How to Select a CMO” Video Series
View all the videos in the series »

Related posts:

PCI Synthesis at DCAT Week 2017
Top Analytical Method Validation Mistakes and How to Avoid Them – Part 2
Top Mistakes in API manufacturing Analytical Method Validation and How to Avoid Them
How to Control Impurities during API drug manufacturing
Ed Price talks cGMP Medical Grade Polymers

About the Author

Ed Price CEO of PCI Synthesis
Ed is President & CEO of SEQENS North America (formerly PCI Synthesis). He serves as a co-chair of the New England CRO/CMO Council and sits on the Industrial Advisory Board for the Department of Chemical Engineering at UMass, Amherst. Ed is also a long standing member of the American Chemical Society and advises the Bulk Pharmaceutical Task Force of the Society of Chemical Manufacturer’s and Affiliates (SOCMA)...

Do you have questions? Talk to Ed.